Remus Pharmaceuticals Ltd. carries a market capitalization of 9.27B, placing it among publicly traded companies globally.
| Market Cap | 9.27B |
| Enterprise Value | N/A |
Remus Pharmaceuticals Ltd.'s stock has declined approximately -13.43563% over the past 52 weeks. The 50-day moving average sits at 742.10, while the 200-day moving average is 717.98.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.43563% |
| 50-Day Moving Average | 742.10 |
| 200-Day Moving Average | 717.98 |
| Average Volume (20 Days) | N/A |